"Agreement on Problems of the Reform Proposal, Including Threats to Health Security and Job Losses"

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on January 27 that the Emergency Response Committee for Drug Price System Reform (hereinafter referred to as the Emergency Committee) and the Federation of Korean Trade Unions have agreed to jointly respond to the government's drug price reduction-focused reform proposal. The intention is to assess together the impact that drug price reforms may have on the competitiveness and employment within the pharmaceutical and bio-pharma industry.


According to the Emergency Committee, Yeonhong Noh, Co-Chairman of the Emergency Committee, visited the Federation of Korean Trade Unions in Yeouido, Seoul, on this day and met with Dongmyeong Kim, Chairman of the Federation of Korean Trade Unions. At the meeting, Chairman Noh conveyed the industry's concerns that a reform centered on drug price reductions could lead to reduced investment in research and development and a weakening of industrial competitiveness. He also raised the possibility that the foundation of health security could be undermined and that there could be a decrease in quality jobs.

From the left, Dongin Lee, Secretary of the Pharmaceutical and Cosmetics Division of the Chemical Federation of Labor Unions; Jaeguk Lee, Chair of the Public Communication Committee of the Emergency Response Committee for Drug Price System Reform; Yeonhong Noh, Chair of the Emergency Response Committee for Drug Price System Reform; Dongmyeong Kim, Chairman of the Federation of Korean Trade Unions; Inseok Hwang, Chairman of the Chemical Federation of Labor Unions; Janghun Lee, Chair of the Pharmaceutical and Cosmetics Division of the Chemical Federation of Labor Unions; Hyunwoo Lee, Executive Director of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. Korea Pharmaceutical and Bio-Pharma Manufacturers Association

From the left, Dongin Lee, Secretary of the Pharmaceutical and Cosmetics Division of the Chemical Federation of Labor Unions; Jaeguk Lee, Chair of the Public Communication Committee of the Emergency Response Committee for Drug Price System Reform; Yeonhong Noh, Chair of the Emergency Response Committee for Drug Price System Reform; Dongmyeong Kim, Chairman of the Federation of Korean Trade Unions; Inseok Hwang, Chairman of the Chemical Federation of Labor Unions; Janghun Lee, Chair of the Pharmaceutical and Cosmetics Division of the Chemical Federation of Labor Unions; Hyunwoo Lee, Executive Director of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. Korea Pharmaceutical and Bio-Pharma Manufacturers Association

View original image

The Federation of Korean Trade Unions agreed with the potential repercussions that drug price reductions could have on the pharmaceutical and bio-pharma industry and the labor market. They also expressed their intention to maintain close communication on related issues going forward.


Both sides agreed that industrial competitiveness and employment stability should be considered together during discussions on drug price system reform. They decided to continue cooperating so that the voices of both industry and labor can be reflected in a balanced manner in policy discussions.



Attending the meeting from the Emergency Committee were Yeonhong Noh, Co-Chairman; Jaeguk Lee, Chairman of the Public Communication Committee; and Hyunwoo Lee, Executive Director of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. From the Federation of Korean Trade Unions, attendees included Chairman Dongmyeong Kim, Inseok Hwang, Chairman of the Chemical Federation of Korea, and Seungil Shin, Chairman of the Medical Workers' Union.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing